New Diagnostics to Infer Risk in Tuberculosis: Is the Term "Latent Tuberculosis Infection" Obsolete?
作者信息
Escalante Patricio, Wilson John W
机构信息
Division of Pulmonary and Critical Care Medicine Mayo Clinic Rochester, Minnesota.
出版信息
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1460-1461. doi: 10.1164/rccm.202101-0131ED.
Abstract
摘要
相似文献
1
New Diagnostics to Infer Risk in Tuberculosis: Is the Term "Latent Tuberculosis Infection" Obsolete?
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1460-1461. doi: 10.1164/rccm.202101-0131ED.
2
[Is case-finding of latent tuberculosis premature at the present time?].
Med Cir Farm. 1950 Oct;174:462-7.
3
[Introduction-Epidemiology of latent and active tuberculosis].
Rev Mal Respir. 2018 Oct;35(8):859-861. doi: 10.1016/j.rmr.2018.08.009. Epub 2018 Sep 19.
4
5-Year Follow-up of Active Tuberculosis Development From Latent Infection in Rural China.
Clin Infect Dis. 2020 Feb 14;70(5):947-950. doi: 10.1093/cid/ciz581.
5
Serum IP-10 in the diagnosis of latent and active tuberculosis.
J Infect. 2015 Dec;71(6):696-8. doi: 10.1016/j.jinf.2015.08.001. Epub 2015 Aug 10.
6
2012: the year in review. Part 1: Tuberculosis.
Int J Tuberc Lung Dis. 2013 Jun;17(6):728-37. doi: 10.5588/ijtld.13.0221.
7
From latent to active TB: are IGRAs of any use?
Thorax. 2016 Jul;71(7):585-6. doi: 10.1136/thoraxjnl-2016-208955.
8
Screening for Latent Tuberculosis (TB) Infection in Low TB Incidence Countries.
Clin Infect Dis. 2020 Feb 3;70(4):716-717. doi: 10.1093/cid/ciz458.
9
Use of insurance claims and electronic health records to assess tuberculosis and latent tuberculosis diagnosis.
Int J Tuberc Lung Dis. 2020 Jul 1;24(7):659-660. doi: 10.5588/ijtld.20.0093.
10
Reactivation tuberculosis: role of surveillance.
Expert Rev Anti Infect Ther. 2016;14(5):501-9. doi: 10.1586/14787210.2016.1173541.
引用本文的文献
1
Cascade of Care in the Management of Latent Tuberculosis Infection in the United States: A Lot to Improve and to Scale Up.
Ann Am Thorac Soc. 2021 Oct;18(10):1620-1621. doi: 10.1513/AnnalsATS.202106-722ED.
本文引用的文献
1
Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection.
EBioMedicine. 2021 Feb;64:103233. doi: 10.1016/j.ebiom.2021.103233. Epub 2021 Feb 18.
2
Antigen-Specific T-Cell Activation Distinguishes between Recent and Remote Tuberculosis Infection.
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1556-1565. doi: 10.1164/rccm.202007-2686OC.
3
Progress Towards Developing a Rapid Triage/Referral Test for Tuberculosis.
Clin Chem. 2020 Aug 1;66(8):995-997. doi: 10.1093/clinchem/hvaa124.
4
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.
Sci Rep. 2020 May 25;10(1):8629. doi: 10.1038/s41598-020-65043-8.
5
New Research Strategies in Latent Tuberculosis Infection.
Arch Bronconeumol (Engl Ed). 2021 Mar;57(3):151-153. doi: 10.1016/j.arbres.2020.01.024. Epub 2020 Mar 17.
6
Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis.
Lancet Respir Med. 2020 Apr;8(4):395-406. doi: 10.1016/S2213-2600(19)30282-6. Epub 2020 Jan 17.
7
Is infection life long?
BMJ. 2019 Oct 24;367:l5770. doi: 10.1136/bmj.l5770.
8
Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures.
PLoS Med. 2019 Apr 23;16(4):e1002786. doi: 10.1371/journal.pmed.1002786. eCollection 2019 Apr.
9
Tuberculosis Elimination, Research, and Respect for Persons.
Am J Respir Crit Care Med. 2019 Mar 1;199(5):560-563. doi: 10.1164/rccm.201809-1623ED.
10
Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
Am J Respir Crit Care Med. 2019 Mar 1;199(5):564-571. doi: 10.1164/rccm.201806-1053PP.
Zotero 插件